| Closed |
SWOG-9521 |
Evaluation of Nuclear p53 in Patients with Epithelial Ovarian Cancer Patients Registered to SWOG-8835, Ancillary |
3/1/1996 |
11/1/1998 |
|
|
Published
|
| Closed |
SWOG-9520 |
Controlled Phase II Study of Doxorubicin and Paclitaxel as Frontline Chemotherapy for Women with Metastatic Breast Cancer |
12/15/1995 |
10/1/1997 |
100% |
|
Published
|
| Closed |
SWOG-9519 |
Evaluation of Tomudex in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck |
6/15/1996 |
11/1/1997 |
68% |
|
Published
|
| Closed |
SWOG-9518 |
Phase II Trial of Continuous Topotecan Infusion in Patients with Advanced Soft Tissue Sarcomas |
4/1/1996 |
10/15/1997 |
55% |
|
Published
|
| Closed |
SWOG-9511 |
A Phase II Study of Trimetrexate, 5-FU and Leucovorin in Unresectable or Metastatic Adenocarcinoma of the Stomach |
1/15/1997 |
11/15/1998 |
100% |
|
Published
|
| Closed |
SWOG-9510 |
Advanced Prostate |
11/1/1996 |
8/15/1999 |
78% |
|
Published
|
| Closed |
SWOG-9509 |
A Randomized Phase III Trial of Paclitaxel plus Carboplatin versus Vinorelbine and Cisplatin in Untreated Advanced Non-Small Cell Lung Cancer |
4/1/1996 |
1/1/1998 |
100% |
|
Published
|
| Closed |
SWOG-9505 |
Evaluation of Pyrazine Diazohydroxide in Patients with Disseminated Malignant Melanoma and No Prior Chemotherapy, Phase II |
1/1/1996 |
8/15/1997 |
55% |
|
Published
|
| Closed |
SWOG-9504 |
A Phase II Trial of Concurrent Cisplatin/VP-16 and Radiotherapy Followed by Consolidation Docetaxel (Taxotere®) in Stage III-B Non-Small Cell Lung Cancer |
10/15/1996 |
12/1/1998 |
100% |
|
Published
|
| Closed |
SWOG-9501 |
A Phase II Trial of Fludarabine and Mitoxantrone (FN) for Treatment of Non-Hodgkin's Lymphoma |
4/1/1995 |
2/15/1996 |
100% |
|
Published
|
| Closed |
SWOG-9500 |
A Phase II Study of 7 + 3 and High Dose Ara-C Induction Therapy with Sequential High-Dose Ara-C Consolidation Therapy for Adults with De Novo Acute Myeloid Leukemia |
12/15/1995 |
4/1/1997 |
100% |
|
Published
|
| Closed |
SWOG-9460 |
Phase IIb Randomized Chemoprevention Trial of N-(4-Hydroxyphenyl) Retinamide (4-HPR) in Transitional Cell Bladder Carcinoma |
6/1/1996 |
10/15/1999 |
34% |
|
Published
|
| Closed |
SWOG-9458 |
Ancillary |
11/15/1995 |
11/1/1998 |
58% |
|
Published
|
| Closed |
SWOG-9457 |
Advanced Bladder |
7/15/1996 |
4/15/2000 |
86% |
|
Published
|
| Closed |
SWOG-9451 |
Resectable Head and Neck |
4/12/1996 |
12/1/2001 |
87% |
|
Published
|
| Closed |
SWOG-9445 |
Prognostic Factor Panel to Predict Preferred Therapy for Node Positive Postmenopausal Breast Cancer Patients (CAF vs. Tamoxifen) (a Companion Protocol to SWOG-8814 [INT-0100, CALGB-9194, EST-4188,… |
2/1/1995 |
10/1/1998 |
66% |
|
Published
|
| Closed |
SWOG-9438 |
NON-HODGKIN'S: Debulking salvage chemo adn stem cell harvest -> TBI/cyclophosphamide -> PBSCT and randmization to IL-2 or obs. |
5/15/1995 |
7/1/2004 |
98% |
|
Published
|
| Closed |
SWOG-9436 (NABTC-9403) (NCI T94-0184) |
A Phase I/II Trial of Paclitaxel (Taxol®) Chemotherapy for Recurrent Malignant Glioma |
4/18/1995 |
2/4/1998 |
95% |
|
Published
|
| Closed |
SWOG-9431 |
Ancillary to SWOG-Coordinated Melanoma Trials |
11/15/1996 |
12/15/2005 |
|
|
Published
|
| Closed |
SWOG-9430 |
Surgical Resection for Stage IV Melanoma |
11/15/1996 |
11/15/2005 |
70% |
|
Published
|
